71 reports

INCREASING DEMAND FOR DIGITAL HEALTHCARE DEVICES Digital healthcare services are expanding gradually and providing health services at a much lower cost.

  • Cardiac Monitoring
  • Cardiovascular Disease
  • Chronic Disease
  • Healthcare
  • Patient Monitoring

COPD is one of the leading causes of death in EU.

  • Chronic Disease
  • Fitbit, Inc.
  • Garmin Ltd.
  • Omron Corporation
  • Sonova Holding AG
  • Untitled
  • PAIN MANAGEMENT AND SURGICAL DEVICES GLOBAL MARKET REVENUE, BY APPLICATION, (2017-2025) ($MN)

MAJOR PLAYERS IN THIS REGION INCLUDE JOHARI DIGITAL HEALTHCARE LTD.

  • Chronic Disease
  • World
  • Market Size
  • Medtronic, Inc.
  • Stryker Corporation

The Business Research Company The Business Research Company July 2018 February 2018 Pharmaceutical Drugs Global Market Opportunities And Strategies To 2021 P A G E | ## P A G E | ## P A G E | ## P A G E | ## P A G E | ## P A G E | ## P A G E | ## P A G E | ## P A G E | ## ## P A G E | ##

  • Chronic Disease
  • World
  • Market Size
  • Novartis AG
  • Pfizer Inc.

GLOBAL MITRAL REPAIR MARKET REVENUE AND FORECASTS TO 2025 (US$ ##.

  • Chronic Disease
  • World
  • Forecast
  • Market Size
  • Abbott

List of Figures: List of Tables: ##.

  • Chronic Disease
  • Abbott Laboratories, Inc.
  • Alere Inc.
  • Beckman Coulter, Inc.
  • CardioGenics Holdings Inc.

SUPPLIER POWER - LOW ##.

  • Chronic Disease
  • Diabetes
  • North America
  • World
  • Market Size
  • Prevalence Of Diabetes Among Asian Countries
  • India Podiatry Services Market Overview

It is growing by ##%-##% year on year.

  • Chronic Disease
  • Epidemiology
  • World
  • Forecast
  • Market Segment
  • Prevalence Of Diabetes Among Asian Countries
  • India Podiatry Services Market Overview

It is growing by ##%-##% year on year.

  • Chronic Disease
  • Epidemiology
  • World
  • Forecast
  • Market Segment

Various non-profit organizations and governments are supporting the ongoing researches on digital healthcare platforms.

  • Chronic Disease
  • Point Of Care Testing
  • World
  • Forecast
  • Alere Inc.

Note: ##.

  • Chronic Disease
  • United States
  • World
  • Forecast
  • Adherium Limited

Digital healthcare in France has evolved massively over the last few years.

  • Chronic Disease
  • World
  • Forecast
  • Market Size
  • 2Morrow Inc.

THE LATAM REGION STARTED E-HEALTH IN 2012 WITH THE AIM TO IMPLEMENT EHR SYSTEMS.

  • Chronic Disease
  • North America
  • United States
  • Cerner Corporation
  • GetWellNetwork, Inc.
  • 3.3.5 South and Central America - PEST Analysis
  • Technological Developments

These watches helps to maintain and keep track of the one' s fitness.

  • Chronic Disease
  • World
  • Forecast
  • Market Size
  • Fitbit, Inc.
  • Nordic Countries 10%
  • Central and Eastern Europe 10%

E-health services were established for R& D in the country.

  • Chronic Disease
  • Diabetes
  • World
  • Medtronic, Inc.
  • Roche Group
  • Dyslipidemia Market - Drivers and Barriers in the 5EU, 2015-2025
  • NATIONAL PUBLIC HEALTH INITIATIVES IN THE 5EU NATIONS

PharmaPoint: Dyslipidemia - Global Drug Forecast and Market Analysis to 2025 Summary Sales of dyslipidemia therapeutics is estimated to be approximately $11.2B across the 7MM in 2015, encompassing the US, 5EU, and Japan. The dyslipidemia market will grow at a strong CAGR of 10.1% over the forecast period, reaching...

  • Chronic Disease
  • AstraZeneca PLC
  • Cerenis
  • Merck & Co., Inc.
  • The Medicines Company

THIS IS LIKELY TO HAVE A SIGNIFICANT IMPACT ON BOTH THE DESIGNING AND DELIVERY OF DIGITAL HEALTHCARE SOLUTIONS.

  • Chronic Disease
  • World
  • Forecast
  • Market Size
  • VOLUNTIS
  • Month & Year
  • 10.5.4 MNM VIEW

The insulin delivery devices market is projected to reach USD 17.85 billion by 2021 from USD 11.54 billion in 2016, growing at a CAGR of 9.1% in the next five years (2016 to 2021). Favorable reimbursement scenario and strong government support in selected countries, technological advancements in insulin delivery devices, growing diabetic...

  • Chronic Disease
  • United States
  • Animas Corporation
  • Becton Property Group
  • Eli Lilly & Co.
  • Month & Year
  • 10.5.4 MNM VIEW

The insulin delivery devices market is projected to reach USD 17.85 billion by 2021 from USD 11.54 billion in 2016, growing at a CAGR of 9.1% in the next five years (2016 to 2021). Favorable reimbursement scenario and strong government support in selected countries, technological advancements in insulin delivery devices, growing diabetic...

  • Chronic Disease
  • United States
  • Animas Corporation
  • Becton Property Group
  • Eli Lilly & Co.

The rate of innovation for digital healthcare technologies is likely to increase.

  • Chronic Disease
  • Pathology
  • World
  • Demand
  • NON-INVASIVE

Johari Digital Healthcare ##.

  • Chronic Disease
  • East Asia
  • North America
  • United States
  • Forecast

Through the agreements, the company aims at creating a better patient experience in the new area of digital healthcare delivery.

  • Chronic Disease
  • United States
  • BioTelemetry Inc.
  • iRhythm Technologies, Inc.
  • Medtronic, Inc.
  • 4.1 BIBLIOGRAPHY

Incidence, prevalence and ##-year all-cause mortality of heart failure in Germany: a study based on electronic healthcare data of more than six million persons.

  • Chronic Disease
  • Hospital
  • United States
  • Forecast
  • American Heart Association, Inc.

List of Figures: List of Tables: ##.

  • Chronic Disease
  • Abbott Laboratories, Inc.
  • Alere Inc.
  • Beckman Coulter, Inc.
  • CardioGenics Holdings Inc.
  • TEVA PHARMACEUTICAL: ASTHMA AWARENESS COLLABORATIONS
  • IN THE FUTURE, WE EXPECT TEVA TO CONTINUE EXPLORING NOVEL DIGITAL SOLUTIONS FOR THE IMPROVEMENT OF PATIENT CARE.

HOWEVER, THE INCREASING POPULARITY OF DIGITAL HEALTHCARE SOLUTIONS AMONG DIFFERENT COMPANIES, AS WELL AS THE PATIENTS IS LIKELY TO ACCELERATE THE OVERALL ADOPTION OF THESE DEVICES IN THE NEAR FUTURE.

  • Chronic Disease
  • North America
  • United States
  • AstraZeneca PLC
  • Novartis AG

One may equip i-CHROMA DUO with a readily available PC printer.

  • Chronic Disease
  • Abbott Laboratories, Inc.
  • Alere Inc.
  • Beckman Coulter, Inc.
  • Boditech Med Inc.

WEB-BASED E-HEALTH PATIENT SERVICE SITES PROVIDE DIRECT CONSUMER OUTREACH AND SERVICES OVER THE INTERNET.

  • Chronic Disease
  • BioTelemetry
  • CardioNet, Inc.
  • LifeWatch AG
  • Medtronic, Inc.

THIS E-HEALTH PROGRAM WILL ALLOW PATIENTS TO GAIN ELECTRONIC ACCESS TO PRESCRIPTION DRUGS AND PRESCRIBING PHYSICIANS.

  • Chronic Disease
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Otsuka Pharmaceutical Co., Ltd.
  • Sanofi S.A.
  • DYSLIPIDEMIA MARKET - 5EU DRIVERS AND BARRIERS, 2014
  • PRESENTS THE DRIVERS AND BARRIERS OF THE ACS MARKET IN THE 5EU DURING THE FORECAST PERIOD.

Dyslipidemia - 5EU Drug Forecast and Market Analysis to 2023 Summary GlobalData estimates that the total market size for the 8MM in 2013 was $15.4bn, comprised of $11.0bn in branded drug sales (72%) and $4.4bn in generic sales (28%). GlobalData expects that the dyslipidemia drug market will grow at a CAGR of 9.4% over...

  • Chronic Disease
  • World
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Pfizer Inc.

PHARMACEUTICAL SALES IN THE T##D MARKET WILL BE DRIVEN BY OVERALL THESE E-HEALTH SERVICES.

  • Chronic Disease
  • Eli Lilly & Co.
  • Lantus group
  • Novo Nordisk Group
  • Sanofi S.A.